Skip to main content
Erschienen in: Wiener klinische Wochenschrift 8/2016

01.12.2016 | original article

Xanthelasma palpebrarum associated with increased cardio-ankle vascular index in asymptomatic subjects

verfasst von: Ali Rıza Akyüz, MD, Turhan Turan, Musluhittin Emre Erkuş, İsmail Gürbak, Selim Kul, Levent Korkmaz, Mustafa Tarık Ağaç, Şükrü Çelik

Erschienen in: Wiener klinische Wochenschrift | Sonderheft 8/2016

Einloggen, um Zugang zu erhalten

Summary

Background

Xanthelasma palpebrarum (XP) is associated with increased risk of ischemic heart disease and myocardial infarction independent of other well-known cardiovascular risk factors. Cardio-ankle vascular index (CAVI) is a novel index of arterial stiffness and important marker of subclinical atherosclerosis. The purpose of this study was to investigate the association between XP and CAVI in asymptomatic subjects.

Methods

Consecutive 50 subjects with XP and age-gender matched 50 control subjects were enrolled. Patients with known atherosclerotic vascular disease were excluded. Arterial stiffness was assessed by CAVI and defined as abnormal if CAVI is ≥ 8.

Results

Subjects with XP had higher mean CAVI than control subjects (8.05 ± 1.72 vs. 6.76 ± 1.18, p < 0.001). Frequency of abnormal CAVI was higher in subjects with XP (n = 27) compared to those without XP (n = 9, 54 vs. 18 %, p < 0.001). There was a significant correlation between XP and CAVI (r = 0.42, p < 0.001). Conditional logistic regression analysis showed that XP (odds ratio OR 8.80, 95 % confidence interval CI 2.63–29.49, p < 0.001) and age (OR 1.17, 95 % CI 1.08–1.26, p < 0.001) were independent predictors for abnormal CAVI.

Conclusion

The study suggests that XP is associated with increased arterial stiffness in asymptomatic subjects.
Literatur
1.
Zurück zum Zitat Christoffersen M, Frikke-Schmidt R, Schnohr P, et al. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011;343:d5497. doi:10.1136/bmj.d5497.CrossRefPubMedPubMedCentral Christoffersen M, Frikke-Schmidt R, Schnohr P, et al. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011;343:d5497. doi:10.1136/bmj.d5497.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Pandhi D, Gupta P, Singal A, et al. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). Postgrad Med J. 2012;88:198–204.CrossRefPubMed Pandhi D, Gupta P, Singal A, et al. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). Postgrad Med J. 2012;88:198–204.CrossRefPubMed
3.
Zurück zum Zitat Akyüz AR, Ağaç MT, Turan T, et al. Xanthelasma is associated with increased amount of epicardial adipose tissue. Med Princ Pract. 2016;25(2):187–90. doi:10.1159/000441846.CrossRefPubMed Akyüz AR, Ağaç MT, Turan T, et al. Xanthelasma is associated with increased amount of epicardial adipose tissue. Med Princ Pract. 2016;25(2):187–90. doi:10.1159/000441846.CrossRefPubMed
4.
Zurück zum Zitat Christoffersen M, Frikke-Schmidt R, Schnohr P, et al. Visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study. Circulation. 2014;129(9):990–8.CrossRefPubMed Christoffersen M, Frikke-Schmidt R, Schnohr P, et al. Visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study. Circulation. 2014;129(9):990–8.CrossRefPubMed
5.
Zurück zum Zitat Bergman R. Xanthelasma palpebrarum and risk of atherosclerosis. Int J Dermatol. 1998;37(5):343–5.CrossRefPubMed Bergman R. Xanthelasma palpebrarum and risk of atherosclerosis. Int J Dermatol. 1998;37(5):343–5.CrossRefPubMed
6.
Zurück zum Zitat Laurent S, Cockcroft J, Van Bortel L, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.CrossRefPubMed Laurent S, Cockcroft J, Van Bortel L, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.CrossRefPubMed
7.
Zurück zum Zitat Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–41.CrossRefPubMed Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–41.CrossRefPubMed
8.
Zurück zum Zitat Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–7.CrossRefPubMed Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–7.CrossRefPubMed
9.
Zurück zum Zitat Yambe M, Tomiyama H, Hirayama Y, et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res. 2004;27(9):625–31.CrossRefPubMed Yambe M, Tomiyama H, Hirayama Y, et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res. 2004;27(9):625–31.CrossRefPubMed
10.
Zurück zum Zitat Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.CrossRefPubMed Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.CrossRefPubMed
11.
Zurück zum Zitat Korkmaz L, Erkan H, Korkmaz AA, et al. Relationship of aortic knob width with cardio-ankle vascular stiffness index and its value in diagnosis of subclinical atherosclerosis in hypertensive patients: a study on diagnostic accuracy. Anadolu Kardiyol Derg. 2012;12(2):102–6.PubMed Korkmaz L, Erkan H, Korkmaz AA, et al. Relationship of aortic knob width with cardio-ankle vascular stiffness index and its value in diagnosis of subclinical atherosclerosis in hypertensive patients: a study on diagnostic accuracy. Anadolu Kardiyol Derg. 2012;12(2):102–6.PubMed
12.
Zurück zum Zitat Kanamoto M, Matsumoto N, Shiga T, et al. Relationship between coronary artery stenosis and cardio-ankle vascular index (CAVI) in patients undergoing cardiovascular surgery. J Cardiovasc Dis Res. 2013;4(1):15–9.CrossRefPubMedPubMedCentral Kanamoto M, Matsumoto N, Shiga T, et al. Relationship between coronary artery stenosis and cardio-ankle vascular index (CAVI) in patients undergoing cardiovascular surgery. J Cardiovasc Dis Res. 2013;4(1):15–9.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Park JB, Park HE, Choi SY, et al. Relation between Cardio-Ankle Vascular Index and Coronary Artery Calcification or Stenosis in Asymptomatic Subjects. J Atheroscler Thromb. 2013;20(6):557–67.CrossRefPubMed Park JB, Park HE, Choi SY, et al. Relation between Cardio-Ankle Vascular Index and Coronary Artery Calcification or Stenosis in Asymptomatic Subjects. J Atheroscler Thromb. 2013;20(6):557–67.CrossRefPubMed
14.
Zurück zum Zitat Okura T, Watanabe S, Kurata M, et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res. 2007;30:335–40.CrossRefPubMed Okura T, Watanabe S, Kurata M, et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res. 2007;30:335–40.CrossRefPubMed
15.
Zurück zum Zitat Nakamura K, Tomaru T, Yamamura S, et al. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J. 2008;72(4):598–604.CrossRefPubMed Nakamura K, Tomaru T, Yamamura S, et al. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J. 2008;72(4):598–604.CrossRefPubMed
16.
Zurück zum Zitat Sekikawa A, Shin C, Curb JD, et al. Aortic stiffness and calcification in men in a population-based international study. Atherosclerosis. 2012;222(2):473–7.CrossRefPubMedPubMedCentral Sekikawa A, Shin C, Curb JD, et al. Aortic stiffness and calcification in men in a population-based international study. Atherosclerosis. 2012;222(2):473–7.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Park HE, Choi SY, Kim MK, et al. Cardio-ankle vascular index reflects coronary atherosclerosis in patients with abnormal glucose metabolism: assessment with 256 slice multi-detector computed tomography. J Cardiol. 2012;60(5):372–6.CrossRefPubMed Park HE, Choi SY, Kim MK, et al. Cardio-ankle vascular index reflects coronary atherosclerosis in patients with abnormal glucose metabolism: assessment with 256 slice multi-detector computed tomography. J Cardiol. 2012;60(5):372–6.CrossRefPubMed
19.
Zurück zum Zitat Agac MT, Bektas H, Korkmaz L, et al. Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults. J Eur Acad Dermatol Venereol. 2015;29(1):26–30.CrossRefPubMed Agac MT, Bektas H, Korkmaz L, et al. Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults. J Eur Acad Dermatol Venereol. 2015;29(1):26–30.CrossRefPubMed
20.
Zurück zum Zitat Jain A, Goyal P, Nigam PK, et al. Xanthelasma palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi. Indian J Clin Biochem. 2007;22(2):151–53.CrossRefPubMedPubMedCentral Jain A, Goyal P, Nigam PK, et al. Xanthelasma palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi. Indian J Clin Biochem. 2007;22(2):151–53.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Segal P, Insull W Jr, Chambless LE, et al. The association of dyslipoproteinemia with corneal arcus and xanthelasma: the Lipid Research Clinics Program Prevalence Study. Circulation. 1986;73:I108–18.CrossRefPubMed Segal P, Insull W Jr, Chambless LE, et al. The association of dyslipoproteinemia with corneal arcus and xanthelasma: the Lipid Research Clinics Program Prevalence Study. Circulation. 1986;73:I108–18.CrossRefPubMed
22.
Zurück zum Zitat Parker F, Odland GF. Experimental xanthoma: a correlative biochemical, histologic, histochemical, and electron microscopic study. Am J Pathol. 1968;53:537–65.PubMedPubMedCentral Parker F, Odland GF. Experimental xanthoma: a correlative biochemical, histologic, histochemical, and electron microscopic study. Am J Pathol. 1968;53:537–65.PubMedPubMedCentral
23.
Zurück zum Zitat Ozdöl S, Sahin S, Tokgözoğlu L. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a). Int J Dermatol. 2008;47(8):785–89.CrossRefPubMed Ozdöl S, Sahin S, Tokgözoğlu L. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a). Int J Dermatol. 2008;47(8):785–89.CrossRefPubMed
Metadaten
Titel
Xanthelasma palpebrarum associated with increased cardio-ankle vascular index in asymptomatic subjects
verfasst von
Ali Rıza Akyüz, MD
Turhan Turan
Musluhittin Emre Erkuş
İsmail Gürbak
Selim Kul
Levent Korkmaz
Mustafa Tarık Ağaç
Şükrü Çelik
Publikationsdatum
01.12.2016
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe Sonderheft 8/2016
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-016-0989-6

Weitere Artikel der Sonderheft 8/2016

Wiener klinische Wochenschrift 8/2016 Zur Ausgabe